Table 1.
CRIPTO concentration in serum.
| Patient group | No. Positive samples/total | CRIPTO concentration (ng/mL) | Statistics | ||
|---|---|---|---|---|---|
| Mean (SD) | Range | Pa | Pb | ||
| Control | 1/15 | 0.77 (2.97) | 0.0–11.48 | – | – |
| SE | 5/15 | 7.61 (24.22) | 0.0–94.36 | 0.1433 | 0.0437 |
| EC | 6/15 | 3.66 (11.59) | 0.0–44.98 | 0.0695 | 0.0178 |
| YST | 1/3 | 1.52 (2.63) | 0.0–4.56 | 0.3137 | 0.1875 |
| GCNIS‐only | 4/5 | 0.59 (0.67) | 0.0–1.63 | 0.0049 | 0.0016 |
| TE | 0/5 | – | – | – | – |
| CH | 0/1 | – | – | – | – |
Mann–Whitney U test of patient group versus control.
Mann–Whitney U test of patient group versus control excluding positive outlier.